Market is unimpressed.
I know of the “potential” of using AI to accelerate drug discovery. However, this is one instance where I wish PYC would just “stick to their knitting”. They are doing really well with the pipeline they have. The risk is “taking their eyes off the ball” at a critical time and diluting valuable cash and Human Resources. This will bring forward a CR, IMO.
Ann: AI Driven Drug Discovery Collaboration with Google Cloud, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.20 |
Change
0.050(4.35%) |
Mkt cap ! $699.9M | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.21 | $1.13 | $387.7K | 327.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 25000 | 1 |
View Market Depth
| Last trade - 16.10pm 23/06/2025 (20 minute delay) ? |
| PYC (ASX) Chart |